Electra Therapeutics at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Electra Therapeutics brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 2357. Its research centres on secondary hemophagocytic lymphohistiocytosis. It covers national claims data on associated conditions, treatments and care patterns.
| Organization | ASH 2026 Attendance |
|---|---|
Electra Therapeutics South San Francisco, CA | |
Clinical-stage biotech developing antibody therapies, led by ELA026, for immune and blood disorders such as hemophagocytic lymphohistiocytosis (HLH). | Booth Exhibiting at Booth 2357 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Find decision makers at Electra Therapeutics
Tell us what you sell and we’ll find the people at Electra Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction